The Form 4 filing for John C.M. Farquhar, Heartflow's chief executive officer, was filed on November 10, 2026. That was also the date of the reported sale. Form 4 is an SEC report of an insider's stock transactions.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-10 |
| Date of Latest Transaction | 2026-11-10 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 38,900 |
| Price | $55.74 |
| Total Transaction Value | $2,168,286.00 |
| Insider | |
| Ticker Symbol | HTFL |
| Company | Heartflow, Inc. |
| Insider Name | Farquhar John C.M. |
| Insider Title | Chief Executive Officer |
| Sector - Industry | Healthcare - Health Information Services |
| Holdings | |
| Total Shares Owned After Transaction | 251,983 |
| Position Size Change | 13.37% |
| Filing | |
| Filing Date | 2026-11-10 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of HTFL shares, reported under transaction code S. The record lists one transaction.
What was the average price of the transaction?
The average sale price was $55.74 per share.
How did this transaction affect the insider's holdings?
The sale reduced his reported holdings by 38,900 shares, leaving 251,983 shares afterward. He sold 13.37% of the shares he held before the sale.
What's the total transaction value?
The total transaction value was $2,168,286.00 for the single reported sale.
Are there any special circumstances around this transaction?
The filing information includes a Rule 10b5-1 trading-plan reference. These plans set trading instructions in advance. The available details do not show whether the reference applies to this sale or to the filing as a whole. The filing's footnote text is unavailable here, so the reference's scope cannot be confirmed. The plan's terms, adoption date and trading schedule remain unknown. The reference alone does not show that the sale met the rule's legal requirements.
For research purposes only; not investment advice.